BeiGene Unveils Proposed Name Change to BeOne Medicines

Today our company unveiled an exciting next step in our journey as a global leader in oncology with our proposed new name: BeOne Medicines Ltd. The name reaffirms our commitment to develop innovative medicines to eliminate cancer by partnering with the global community to serve as many patients as possible.??

We are focused on working as one team with one vision, harnessing the transformative power of global collaboration and multisectoral partnerships to drive innovations that eradicate cancer.?

Since our founding in 2010 by a small group of visionary scientists and entrepreneurs, we have grown into a global oncology leader with nearly 11,000 employees spanning five continents -- all united in our mission to make a difference for patients worldwide. From our humble beginnings, we’ve evolved into a leader in cancer treatment, advancing ground-breaking therapies and prioritizing access for those who need it most.?

?

As we prepare to embrace this new name, our mission and commitment to the oncology community is stronger than ever. Our commitment is evident in the advancement of the industry’s largest and most promising pipeline, spanning multiple treatment modalities in both hematology and solid tumors. The dedication of our team has been extraordinary, and we’re accelerating our global growth strategy to bring even more innovative solutions to patients around the world.?

To date, we’ve reached over 1.4 million patients, and this year, we plan to initiate clinical trials for more than ten potential new medicines. Our unique, cost-advantaged global capabilities enable us to generate breakthrough molecules faster, advance clinical trials at lower costs, and secure regulatory approvals across 70+ countries for our three internally developed commercial medicines. With over 60 potential therapies currently in clinical development, our relentless pursuit of scientific excellence continues to propel us forward as a global leader in oncology.?

We look forward to sharing more as we continue to make strides across the company.?